CRISPR/Cas9-mediated knockout of SLC38A5 clearly demonstrated the tumor promoting role of SLC38A5 in both in vitro cell line models as well as in in vivo xenograft mouse models. This evidence concerns the gene SLC38A5 and neoplasm.